Navigation Links
Chlamydia Vaccine a Step Closer to Reality

Scientists at Queensland University of Technology are one step closer to developing a world-first vaccine //to protect women against contracting the most common sexually-transmitted disease, Chlamydia.

A major international vaccine company has awarded QUT a funding boost of more than $300,000 to continue its research into Chlamydia and work towards developing a vaccine specifically targeting adolescent women.

Professor Peter Timms, from QUT's Institute of Health and Biomedical Innovation (IHBI), said a team of researchers had already identified certain proteins that were able to protect against Chlamydia infection.

"We've been testing these proteins as part of animal trials...and we think we've got the answer. It is possible that within three to five years we'll be finished the animal trials and be looking at clinical trials in humans."

Professor Timms said the funding would allow QUT to evaluate the effectiveness of Chlamydia prevention methods developed at the university, as well as compare and test possible other prevention methods being developed.

He said once a vaccine had been developed it could be administered via a patch, similar to ones used by smokers for nicotine.

"Patches are a good way to deliver proteins to a part of the body's immune system and they are also easy and user-friendly."

He said with rates of Chlamydia infection in some Australian communities as high as 12 per cent of the female population, there was a "real need" to develop a vaccine.

"Chlamydia is the most common infectious disease in the world and results in infertility in women and long-term chronic pelvic pain," he said.

"There are antibiotics to treat Chlamydia, but there's no vaccine to prevent it. In many cases women don't know they are infected because there are not really any physical signs or symptoms, so by and large they don't get treatment."

Professor Timm s said the fact that a large vaccine company had selected QUT to help develop Chlamydia vaccines points to the value of the work being done at the university.

"Despite this current injection of funds, further work and funding is still needed to take this current research through to a vaccine product," he said.

QUT researchers working on the project are part of IHBI's Cells and Tissue Domain and include Professors Peter Timms, Ken Beagley, Associate Professor Louise Hafner, Celia Berry and Chris Barker.

Source-Bio-Bio Technology
'"/>




Related medicine news :

1. Chlamydia toxin- a secret killer
2. One In Nine Young Women Diagnosed With Chlamydia Infection
3. UK Govt Says On Course For National Chlamydia Screening
4. Chlamydia Screening To Be Offered With Emergency Contraception
5. Home Chlamydia Test
6. Chlamydial Vaccine for Humans in the Pipeline
7. Mouse Model Demonstrates Immune System Reaction In Chlamydia Infection
8. Newly Identified Strains Of Chlamydia Trachomatis – A Gateway To New Disease
9. A Combined Research for Producing Chlamydia Vaccine Begins
10. Recurring Chlamydia Infections Common in Teenage Girls
11. Vaccine to quit smoking?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... Nevada (PRWEB) , ... June 24, 2016 , ... ... Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations ... in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a ...
(Date:6/24/2016)... ... 24, 2016 , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. ... service members that have been wounded in battle and their families. Venture Construction Group ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: